Inventor · disambiguated record
George Fromm
Also filed as: FROMM GEORGE · FROMM GEORGE R
38 granted patents·32 pending applications·139 citations·filing 1979–2024
97Inventor score
Files withSHATTUCK LABS INC49HEAT BIOLOGICS INC16CURTIS HELENE IND INC2KOPFKINO IP LLC2FROMM GEORGE R1
Top patents by PatentIndex Score
70 records- 0197US10988517B2Heterodimeric proteins for modulating gamma delta T cellsSHATTUCK LABS INC·Filed 2020·Granted Apr 27, 2021·4 cites·18 claims
- 0296US11834488B2VSIG8-based chimeric proteinsSHATTUCK LABS INC·Filed 2021·Granted Dec 5, 2023·2 cites·19 claims
- 0396US11643447B2Heterodimeric proteins for modulating gamma delta T cellsSHATTUCK LABS INC·Filed 2022·Granted May 9, 2023·2 cites·19 claims
- 0496US11547742B1Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2021·Granted Jan 10, 2023·2 cites·20 claims
- 0596US10899817B2TIGIT- and light-based chimeric proteinsSHATTUCK LABS INC·Filed 2020·Granted Jan 26, 2021·3 cites·20 claims
- 0696US10183060B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2016·Granted Jan 22, 2019·15 cites·23 claims
- 0795US10995127B2Heterodimeric proteins and uses thereofSHATTUCK LABS INC·Filed 2019·Granted May 4, 2021·8 cites·14 claims
- 0895US10646545B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2018·Granted May 12, 2020·5 cites·23 claims
- 0994US11780897B2Heterodimeric proteins and uses thereofSHATTUCK LABS INC·Filed 2021·Granted Oct 10, 2023·2 cites·20 claims
- 1094US10927159B2TIGIT- and light-based chimeric proteinsSHATTUCK LABS INC·Filed 2020·Granted Feb 23, 2021·2 cites·26 claims
- 1194US10660936B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2018·Granted May 26, 2020·4 cites·23 claims
- 1294US10653748B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2019·Granted May 19, 2020·4 cites·20 claims
- 1393US11896618B2FLT3L-based chimeric proteinsSHATTUCK LABS INC·Filed 2020·Granted Feb 13, 2024·2 cites·3 claims
- 1493US10449233B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2018·Granted Oct 22, 2019·7 cites·25 claims
- 1593US10188701B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2017·Granted Jan 29, 2019·6 cites·23 claims
- 1692US11654180B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2020·Granted May 23, 2023·2 cites·23 claims
- 1791US11098093B2Heterodimeric proteins for modulating gamma delta T cellsSHATTUCK LABS INC·Filed 2020·Granted Aug 24, 2021·2 cites·16 claims
- 1891US10543253B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2018·Granted Jan 28, 2020·4 cites·25 claims
- 1991US10525102B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2018·Granted Jan 7, 2020·4 cites·25 claims
- 2091US10493128B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2018·Granted Dec 3, 2019·4 cites·25 claims
- 2190US11332509B2Methods of making and using extracellular domain-based chimeric proteinsSHATTUCK LABS INC·Filed 2018·Granted May 17, 2022·2 cites·20 claims
- 2290US10513548B2CSF1R-based chimeric proteinsSHATTUCK LABS INC·Filed 2018·Granted Dec 24, 2019·3 cites·16 claims
- 2390US10086042B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2017·Granted Oct 2, 2018·4 cites·23 claims
- 2489US12492236B2Fusion proteins for the treatment of cardiometabolic diseasesSHATTUCK LABS INC·Filed 2024·Granted Dec 9, 2025·0 cites·6 claims
- 2589US10780161B2Vector co-expressing vaccine and costimulatory moleculesHEAT BIOLOGICS INC·Filed 2018·Granted Sep 22, 2020·2 cites·13 claims
- 2689US10758611B2Vector co-expressing vaccine and costimulatory moleculesHEAT BIOLOGICS INC·Filed 2018·Granted Sep 1, 2020·2 cites·13 claims
- 2789US2024368242A1Methods of making and using extracellular domain-based chimeric proteinsSHATTUCK LABS INC·Filed 2024·Application pending·0 cites
- 2888US12145975B2Fusion proteins for the treatment of cardiometabolic diseasesSHATTUCK LABS INC·Filed 2024·Granted Nov 19, 2024·0 cites·1 claims
- 2988US11267857B2CSF1R-based chimeric proteinsSHATTUCK LABS INC·Filed 2019·Granted Mar 8, 2022·2 cites·18 claims
- 3088US11192934B2VSIG8-based chimeric proteinsSHATTUCK LABS INC·Filed 2019·Granted Dec 7, 2021·2 cites·10 claims
- 3188US2024190939A1Tigit- and light-based chimeric proteinsSHATTUCK LABS INC·Filed 2024·Application pending·0 cites
- 3287US11267856B2CSF1R-CD40L chimeric proteinsSHATTUCK LABS INC·Filed 2018·Granted Mar 8, 2022·2 cites·14 claims
- 3387US10780121B2FLT3L-based chimeric proteinsSHATTUCK LABS INC·Filed 2019·Granted Sep 22, 2020·2 cites·7 claims
- 3487US2025066446A1Fusion proteins for the treatment of cardiometabolic diseasesSHATTUCK LABS INC·Filed 2024·Application pending·0 cites
- 3587US2025145681A1Fusion proteins for the treatment of cardiometabolic diseasesSHATTUCK LABS INC·Filed 2024·Application pending·0 cites
- 3686US11192933B2VSIG8-based chimeric proteinsSHATTUCK LABS INC·Filed 2018·Granted Dec 7, 2021·2 cites·10 claims
- 3786US2025332219A1Compositions and methods for adjoining type i and type ii extracellular domains as heterologous chimeric proteinsKOPFKINO IP LLC·Filed 2024·Application pending·0 cites
- 3884US2024067698A1Vsig8-based chimeric proteinsSHATTUCK LABS INC·Filed 2023·Application pending·0 cites
- 3983US12071465B2Methods of making and using extracellular domain-based chimeric proteinsSHATTUCK LABS INC·Filed 2022·Granted Aug 27, 2024·0 cites·20 claims
- 4081US10046047B2Vector co-expressing vaccine and costimulatory moleculesHEAT BIOLOGICS INC·Filed 2016·Granted Aug 14, 2018·2 cites·13 claims
- 4181US2022227831A1Tigit- and light-based chimeric proteinsSHATTUCK LABS INC·Filed 2022·Application pending·0 cites
- 4277US2023220030A1Heterodimeric proteins and uses thereofSHATTUCK LABS INC·Filed 2023·Application pending·0 cites
- 4376US2022144909A1Csf1r-based chimeric proteinsSHATTUCK LABS INC·Filed 2022·Application pending·0 cites
- 4471US2024011101A1Method of determining resistance to checkpoint inhibitor therapiesSHATTUCK LABS INC·Filed 2021·Application pending·0 cites
- 4571US2024016892A1Methods of treating cancer using tigit-and light-based chimeric proteinsSHATTUCK LABS INC·Filed 2021·Application pending·0 cites
- 4669US2021000945A1Vector co-expressing vaccine and costimulatory moleculesHEAT BIOLOGICS INC·Filed 2020·Application pending·0 cites
- 4768US12178847B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsKOPFKINO IP LLC·Filed 2020·Granted Dec 31, 2024·0 cites·18 claims
- 4868US2023045794A1Nk cell-directed chimeric proteinsSHATTUCK LABS INC·Filed 2022·Application pending·0 cites
- 4968US2024122983A1Flt3l-based chimeric proteinsSHATTUCK LABS INC·Filed 2023·Application pending·0 cites
- 5065US2021379153A1Combination therapies comprising sirp alpha-based chimeric proteinsSHATTUCK LABS INC·Filed 2019·Application pending·0 cites
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when George Fromm files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →